You Position: Home > Journal Detail
All Issues
2024:
2023:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2022:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2021:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2020:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2019:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2018:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2017:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2016:
2015:
2014:
2013:
2012:
2011:
2010:
2009:
2008:
2007:
2006:
2005:
2004:
2003:
Clinical Medication Journal
- ISSN:
- 1672-3384
- CN:
- 11-4989/R
- Founded in:
- 2003
- Sponsor:
- 北京市药品监督管理局
- Indexed in:
- ISTIC
- Email:
- zazhi@vip.sina.com
本刊自创刊以来一直秉承结合一线医师在药物治疗实践中常见问题，充分结合临床医学、药学专家的优势，详尽介绍著名临床医学、药学专家用药心得，循证医学的最新进展以及国内外最新临床用药信息、药物发展最新动态为宗旨。
- 1: A single center retrospective study on sintilimab-induced thyroid immune-related adverse events in treatment of gastric cancer (孙颖丽 刘一 任晓蕾 黄琳 封宇飞)
- 2: Effect of clinical pharmaceutical care on rational use of nirmatrelvir/ritonavir tablets (支旭然 邹杨 高丽君 覃旺军 孔旭东 赵莉 郭冬杰 李朋梅 张相林 刘丽宏)
- 3: Signal mining of respiratory adverse events caused by trastuzumab deruxtecan based on the FDA adverse event reporting system database (唐雨辰 易彬 杨健 张子祥)
- 4: Epidemiology and influencing factors analysis of bloodstream infection of carbapenem-resistant Klebsiella pneumoniae (徐小燕 陈集志 胡文弋 宁丽萍)
- 5: Clinical comprehensive evaluation of lipid-lowering drugs in Heilongjiang Province (吴禹蒙 宋佳 刘利龙 孙向菊 徐娜 闫虹 吴玉波)
- 6: A case of drug therapy practice of pneumocystis jirovecii pneumonia secondary to COVID-19 in patient with renal insufficiency after renal transplantation (王小营 李忠东)
- 7: Progress of clinical research on pimavanserin (闫奕龙 杨莉 赵志刚)
- 8: Hearing and vision damage and abdominal skin bulge caused by rituximab:a case report (牛倩倩 潘丰德 邱雯)
- 9: Research progress on influencing factors of medication adherence in organ transplant recipients (余馨 安卓玲 冯欣 杨辉)
- 10: Pharmacological treatment and monitoring of bronchiectasis co-infection caused by mycobacterium avium:a case report (祝晓雨 王静宜 陈瑞玲)
- 11: Analysis of clinical features of immune-associated myocarditis induced by camrelizumab (孙景宇 陈蓉 孟伟康)
- 12: A therapeutic drug for myelodysplastic syndrome:pevonedistat (王堂乐 王鹏 韩语轩 郭兆霖 曹爽 刘彦)
- 13: Analysis of efficacy of intrathecal infusion of hydromorphone and its combination with ketamine and gabapentin in the treatment of refractory cancer pain (李娜 李敏 杨利珍 张生茂)
- 14: A new oral isocitrate dehydrogenase 1 inhibitor:olutasidenib (赵尹瑜 黄婧 黄琳)
- 15: Analysis of essential medicines use in elderly patients with common chronic disease (王天琳 刘传斌 蔡乐 曹丰 梁锦湄 刘淼 陈孟莉 范利)
- 16: Research progress on population pharmacokinetics of sirolimus in pediatric diseases (刘博 徐晓琳 赵一鸣 王晓玲 成晓玲)
- 17: Comprehensive clinical evaluation of omalizumab in the treatment of moderate-to-severe bronchial asthma in children (周鹏翔 沙莉 刘玲 向莉 程吟楚 刘维 杨毅恒 翟所迪 周薇)
- 18: Construction of clinical comprehensive evaluation index system for sodium-glucose cotransporter 2 inhibitor of type 2 diabetes mellitus based on delphi method and analytic hierarchy process (王璐 曾露 郭洁茹 桂玲 张文婷 贡雪芃 刘东 魏安华)